SC
COV

Scotia Capital’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Scotia Capital’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,925
Closed -$299K – 670
2014
Q4 		$299K Sell
2,925
-652
-18% -$62.5K 0.01% 507
2014
Q3 		$310K Buy
3,577
+100
+3% +$8.86K 0.01% 495
2014
Q2 		$314K Buy
3,477
+110
+3% +$8.23K 0.01% 476
2014
Q1 		$248K Buy
3,367
+112
+3% +$7.81K 0.01% 498
2013
Q4 		$221K Buy
+3,255
New +$212K 0.01% 490

Scotia Capital's COV Position: Q1 2015 in Review

Scotia Capital sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,925 shares — an estimated $299K sold.

Scotia Capital first reported a position in COV in Q4 2013 and held it in 5 quarters. The position peaked at $314K in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Scotia Capital reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Scotia Capital sold 2,925 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $299K.
  • Scotia Capital first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2013 and held it in 5 quarters.
  • Scotia Capital's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $314K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Scotia Capital's 13F filing for Q1 2015, filed 15 May 2015.